Clinical Trial Update: Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing paricalcitol and hydroxychloroquine in combination with gemcitabine and nab-paclitaxel for advanced pancreatic cancer has completed, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Abraxane (nab-paclitaxel) (nab-paclitaxel)
• Gemzar (gemcitabine) (gemcitabine)
• Plaquenil (hydroxychloroquine) (hydroxychloroquine)
• Zemplar (paricalcitol) (paricalcitol)

Snippet

Sponsor: Emory University | Conditions: Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2026-01-23